Avanos Medical (NYSE:AVNS – Get Free Report) will be posting its quarterly earnings results before the market opens on Wednesday, October 30th. Analysts expect Avanos Medical to post earnings of $0.36 per share for the quarter. Avanos Medical has set its FY24 guidance at $1.30-1.45 EPS and its FY 2024 guidance at 1.300-1.450 EPS.
Avanos Medical (NYSE:AVNS – Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.05. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The business had revenue of $171.70 million for the quarter, compared to analyst estimates of $170.67 million. During the same period last year, the firm earned $0.24 earnings per share. Avanos Medical’s revenue for the quarter was up 1.4% compared to the same quarter last year. On average, analysts expect Avanos Medical to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Avanos Medical Stock Down 0.7 %
Shares of AVNS opened at $22.35 on Thursday. The company has a current ratio of 2.28, a quick ratio of 1.49 and a debt-to-equity ratio of 0.13. Avanos Medical has a 12 month low of $17.24 and a 12 month high of $25.36. The firm’s 50 day moving average is $23.48 and its 200-day moving average is $21.42. The stock has a market capitalization of $1.03 billion, a PE ratio of -16.80 and a beta of 0.91.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on AVNS
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Recommended Stories
- Five stocks we like better than Avanos Medical
- What is a Stock Market Index and How Do You Use Them?
- A $1.75 Billion Gamble: Can Lucid Ignite Growth?
- Short Selling: How to Short a Stock
- The Rally in Lockheed Martin and RTX Can Continue: Here’s Why
- What Does Downgrade Mean in Investing?
- 3 Undervalued Technology Stocks With Big Rebound Potential
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.
